Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Multiple Sclerosis

Free Subscription Articles published in Mult Scler Retrieve available abstracts of 349 articles: HTML format

Single Articles

April 2008
1. PUEYO V , Martin J, Fernandez J, Almarcegui C, et al
   Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. O'SULLIVAN RJ , Brown IG, Pender MP
   Apneusis responding to buspirone in multiple sclerosis.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. KRAKAUER M , Sorensen P, Khademi M, Olsson T, et al
   Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-{beta} treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. VOLLMER T , Panitch H, Bar-Or A, Dunn J, et al
   Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. BAR-ZOHAR D , Agosta F, Goldstaub D, Filippi M, et al
   Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. CHENG Q , Miao L, Zhang J, Guan YT, et al
   Clinical features of patients with multiple sclerosis from a survey in Shanghai, China.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. ABO-KRYSHA N , Rashed L
   The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. SELLEBJERG F , Datta P, Larsen J, Rieneck K, et al
   Gene expression analysis of interferon-{beta} treatment in multiple sclerosis.
   Mult Scler. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. LEBRUN C , Debouverie M, Vermersch P, Clavelou P, et al
   Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
   Mult Scler. 2008;14:399-405.
   PubMed     Related articles    Abstract available
   
   
   March 2008
10. FLACHENECKER P , Meissner H
    Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Mult Scler. 2008;14:274-7.
    PubMed     Related articles    Abstract available
    
    
    
11. SERARSLAN G , Okuyucu E, Melek I, Hakverdi S, et al
    Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
    Mult Scler. 2008;14:259-61.
    PubMed     Related articles    Abstract available
    
    
    January 2008
12. MATSUSHITA T , Matsuoka T, Ishizu T, Kikuchi H, et al
    Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. TREMLETT H , Zhao Y, Devonshire V
    Natural history of secondary-progressive multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SEVE P , Le Scanff J, Renoux C, Broussolle C, et al
    Uveitis associated with multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. GALIMBERTI D , Fenoglio C, Scalabrini D, De Riz M, et al
    MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. KURBAN S , Akpinar Z, Mehmetoglu I
    Receptor Activator of Nuclear Factor KappaB Ligand (RANKL) and Osteoprotegerin Levels in Multiple Sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles   
    
    
    
17. CONSTANTINESCU CS , Vilisar J, Harikrishnan S, Suri M, et al
    Ehlers-Danlos syndrome and multiple sclerosis: a possible association.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. ZWEMMER JN , Bot JC, Jelles B, Barkhof F, et al
    At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. LEONE MA , Bonissoni S, Collimedaglia L, Tesser F, et al
    Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. WU XM , Wang C, Zhang KN, Huang G, et al
    Balo's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. TZORTIS V , Skriapas K, Mitsogiannis I, Gravas S, et al
    Sexual dysfunction in newly diagnosed multiple sclerosis women.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. PARRATT J , Tavondale R, O'Riordan J, Parratt D, et al
    Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SAUTER C , Zebenholzer K, Zeitlhofer J, Vass K, et al
    A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. GRANIERI E , Monaldini C, De Gennaro R, Guttmann S, et al
    Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. CORREALE J , Roca M, Fiol M, Martin ME, et al
    Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. KARENBERG A
    Multiple sclerosis on-screen: from disaster to coping.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. KALMAN B , Vyshkina T
    Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. RODRIGUES F , Carvalho A, Santos M, Maciel P, et al
    T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. MILLER A , Spada V, Beerkircher D, Kreitman RR, et al
    Long-term (up to 22 years), open-label,compassionate-use study of glatiramer acetatein relapsingremitting multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. CASADIO M , Sanguineti V, Morasso P, Solaro C, et al
    Abnormal sensorimotor control, but intact forcefield adaptation, in multiple sclerosis subjects with no clinical disability.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. HABEK M , Brinar VV, Hajnsek S
    The association of multiple sclerosis and Hodgkin's disease: the role of Epstein-Barr virus infection.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. ZAADSTRA BM , Chorus AM, Van Buuren S, Kalsbeek H, et al
    Selective association of multiple sclerosis withinfectious mononucleosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. GOERTSCHES R , Baranzini SE, Morcillo C, Nos C, et al
    Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. ROVARIS M , Judica E, Sastre-Garriga J, Rovira A, et al
    Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. FAINARDI E , Rizzo R, Melchiorri L, Stignani M, et al
    CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis.
    Mult Scler. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. MOTL RW , Arnett PA, Smith MM, Barwick FH, et al
    Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis.
    Mult Scler. 2008;14:140-2.
    PubMed     Related articles    Abstract available
    
    
    
37. BANWELL BL
    Through the eyes of a child: research insights gained through the study of childhood multiple sclerosis.
    Mult Scler. 2008;14:4-5.
    PubMed     Related articles   
    
    
    
38. POLMAN CH
    Early diagnosis of multiple sclerosis-still a challenge?
    Mult Scler. 2008;14:2-3.
    PubMed     Related articles   
    
    
    
39. MCHUGH JC , Galvin PL, Murphy RP
    Retrospective comparison of the original and revised McDonald criteria in a general neurology practice in Ireland.
    Mult Scler. 2008;14:81-5.
    PubMed     Related articles    Abstract available
    
    
    November 2007
40. KESSELRING J , Coenen M, Cieza A, Thompson A, et al
    Developing the ICF Core Sets for multiple sclerosis to specify functioning.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. FAZEKAS F , Strasser-Fuchs S, Enzinger C, Ropele S, et al
    Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. PETERLIN B , Lovrecic L, Ristic S, Starcevic-Cizmarevic N, et al
    PAI and TPA gene polymorphisms in multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. LINDSEY JW , Patel S
    PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. PATTEN SB , Williams JV, Metz L
    Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. RON M , Summers MM, Fisniku L, Anderson VM, et al
    Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. LEHMANN HC , Hartung HP, Kieseier BC
    Leopold Ordenstein: on paralysis agitans and multiple sclerosis.
    Mult Scler. 2007;13:1195-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
47. PENNER IK , Bechtel N, Raselli C, Stocklin M, et al
    Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control.
    Mult Scler. 2007;13:1161-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
48. BAUM K , O'Leary C, Coret Ferrer F, Klimova E, et al
    Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
    Mult Scler. 2007;13:1153-60.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
49. TURNER AP , Kivlahan DR, Sloan AP, Haselkorn JK, et al
    Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model.
    Mult Scler. 2007;13:1146-52.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
50. KUMPFEL T , Schwan M, Pollmacher T, Yassouridis A, et al
    Time of interferon-{beta} 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients.
    Mult Scler. 2007;13:1138-1145.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
51. BOZ C , Oger J, Gibbs E, Grossberg SE, et al
    Reduced effectiveness of long-term interferon-{beta} treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study.
    Mult Scler. 2007;13:1127-1137.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
52. BHIGJEE AI , Moodley K, Ramkissoon K
    Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study.
    Mult Scler. 2007;13:1095-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
53. AMOR S , Giovannoni G
    Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis are we there yet?
    Mult Scler. 2007;13:1083-1085.
    PubMed     Related articles       Free Full Text
    
    
    
54. KOONTZ D , Alshekhlee A
    Embolia cutis medicamentosa following interferon beta injection.
    Mult Scler. 2007;13:1203-4.
    PubMed     Related articles   
    
    
    
55. PACHNER AR
    Neutralizing anti-IFNbeta antibodies: clarity and confusion.
    Mult Scler. 2007;13:1081-2.
    PubMed     Related articles   
    
    
    
56. TOMASSINI V , De Giglio L, Reindl M, Russo P, et al
    Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
    Mult Scler. 2007;13:1086-94.
    PubMed     Related articles    Abstract available
    
    
    October 2007
57. WOOLMORE JA , Stone MJ, Holley SL, Jenkinson PM, et al
    Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. KRONE B , Pohl D, Rostasy K, Kahler E, et al
    Common infectious agents in multiple sclerosis: a case control study in children.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. WIESEMANN E , Deb M, Trebst C, Hemmer B, et al
    Effects of interferon-{beta} on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-{beta} treatment in patients with multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. COSTELLOE L , O'rourke K, McGuigan C, Walsh C, et al
    The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. SIMEONI MC , Auquier P, Fernandez O, Flachenecker P, et al
    Validation of the Multiple Sclerosis International Quality of Life questionnaire.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. PENG F , Zhang B, Zhong X, Li J, et al
    Serum uric acid levels of patients with multiple sclerosis and other neurological diseases.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. MANCONI M , Rocca MA, Ferini-Strambi L, Tortorella P, et al
    Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. OKUYUCU EE , Okuyucu S, Karazincir S, Akoglu E, et al
    Acute 'upside-down' visual inversion due to multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. VILLAR LM , Garcia-Barragan N, Espino M, Roldan E, et al
    Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. KOCH M , Mostert J, Arutjunyan A, Stepanov M, et al
    Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. SERARSLAN G , Okuyucu EE, Melek IM, Hakverdi S, et al
    Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. AGUIRREGOMOZCORTA M , Ramio-Torrenta LI, Gich J, Quiles A, et al
    Paroxysmal dystonia and pathological laughter as a first manifestation of multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. KIMISKIDIS VK , Sakellari I, Tsimourtou V, Kapina V, et al
    Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. FLACHENECKER P , Meissner H
    Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. MUNTEIS E , Andreu M, Martinez-Rodriguez JE, Ois A, et al
    Manometric correlations of anorectal dysfunction and biofeedback outcome in patients with multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. BEER S , Aschbacher B, Manoglou D, Gamper E, et al
    Robot-assisted gait training in multiple sclerosis: a pilot randomized trial.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. GREVE B , Simonenko R, Illes Z, Peterfalvi A, et al
    Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. GOLDMAN M , Ann Marrie R, Cohen JA
    Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. 
    Abstracts of the 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis and the 12th Annual Conference of Rehabilitation in Multiple Sclerosis. October 11-14, 2007. Prague, Czech Republic.
    Mult Scler. 2007;13 Suppl 2:S7-273.
    PubMed     Related articles   
    
    
    September 2007
76. LINCOLN N , Radford K
    Cognitive abilities as predictors of safety to drive in people with multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. KUUSISTO H , Heikki H, Saara K, Esko K, et al
    Human herpes virus 6 and multiple sclerosis: a Finnish twin study.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. REJDAK K , Petzold A, Stelmasiak Z, Giovannoni G, et al
    Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. LIDEGAARD O , Svendsen AL
    Sexual habits before multiple sclerosis: a National case control study.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. NAGELS G , D'Hooghe MB, Kos D, Engelborghs S, et al
    Within-session practice effect on paced auditory serial addition test in multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. IEZZONI LI , Ngo L, Kinkel P
    Working-age persons with multiple sclerosis and access to disease-modifying medications.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. GONSETTE RE
    Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. DALGAS U , Stenager E, Ingemann-Hansen T
    Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. TREMLETT HL , Oger J
    Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. PETERSON EW , Cho CC, Finlayson ML
    Fear of falling and associated activity curtailment among middle aged and older adults with multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. RAO SAJJA B , Narayana PA, Wolinsky J, Ahn CW, et al
    Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. KERN S , Ziemssen T
    Brain immune communication psychoneuroimmunology of multiple sclerosis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. MOTL RW , Gosney JL
    Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis.
    Mult Scler. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. VUGER-KOVACIC D , Gregurek R, Kovacic D, Vuger T, et al
    Relation between anxiety, depression and locus of control of patients with multiple sclerosis.
    Mult Scler. 2007;13:1065-7.
    PubMed     Related articles    Abstract available
    
    
    
90. TURPIN KV , Carroll LJ, Cassidy JD, Hader WJ, et al
    Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs.
    Mult Scler. 2007;13:1038-45.
    PubMed     Related articles    Abstract available
    
    
    
91. DEBOUVERIE M , Pittion-Vouyovitch S, Louis S, Guillemin F, et al
    Validity of a French version of the fatigue impact scale in multiple sclerosis.
    Mult Scler. 2007;13:1026-32.
    PubMed     Related articles    Abstract available
    
    
    
92. CONTELLOE L , Hutchinson M
    Is a 20% change in MSFC components clinically meaningful?
    Mult Scler. 2007;13:1076.
    PubMed     Related articles   
    
    
    
93. THOMPSON AJ
    Professor Ian McDonald (1933 2006).
    Mult Scler. 2007;13:953-4.
    PubMed     Related articles   
    
    
    
94. SOBOCKI P , Pugliatti M, Lauer K, Kobelt G, et al
    Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
    Mult Scler. 2007;13:1054-64.
    PubMed     Related articles    Abstract available
    
    
    
95. SOLARI A , Motta A, Radice D, Mendozzi L, et al
    A shortened version of PASAT-3 is feasible.
    Mult Scler. 2007;13:1020-5.
    PubMed     Related articles    Abstract available
    
    
    
96. WATANABE S , Misu T, Miyazawa I, Nakashima I, et al
    Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.
    Mult Scler. 2007;13:968-74.
    PubMed     Related articles    Abstract available
    
    
    
97. ROCCATAGLIATA L , Rocca M, Valsasina P, Bonzano L, et al
    The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.
    Mult Scler. 2007;13:1068-70.
    PubMed     Related articles    Abstract available
    
    
    August 2007
98. SIMON K , Yang X, Munger K, Ascherio A, et al
    Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis.
    Mult Scler. 2007;13:947-8.
    PubMed     Related articles   
    
    
    
99. SAHIN S , Aksungar FB, Topkaya AE, Yildiz Z, et al
    Increased plasma homocysteine levels in multiple sclerosis.
    Mult Scler. 2007;13:945-6.
    PubMed     Related articles   
    
    
    
100. THOUVENOT E , Hillaire-Buys D, Bos-Thompson MA, Rigau V, et al
     Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis.
     Mult Scler. 2007;13:941-4.
     PubMed     Related articles    Abstract available
     
     
     
101. PAKENHAM KI
     The nature of caregiving in multiple sclerosis: development of the caregiving tasks in multiple sclerosis scale.
     Mult Scler. 2007;13:929-38.
     PubMed     Related articles    Abstract available
     
     
     
102. DE SEZE M , Ruffion A, Denys P, Joseph PA, et al
     The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.
     Mult Scler. 2007;13:915-928.
     PubMed     Related articles    Abstract available
     
     
     
103. HAAS J , Hommes OR
     A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis.
     Mult Scler. 2007;13:900-8.
     PubMed     Related articles    Abstract available
     
     
     
104. LERAY E , Morrissey S, Yaouanq J, Coustans M, et al
     Long-term survival of patients with multiple sclerosis in West France.
     Mult Scler. 2007;13:865-74.
     PubMed     Related articles    Abstract available
     
     
     
105. HERRERA B , Cader M, Dyment D, Bell J, et al
     Multiple sclerosis susceptibility and the X chromosome.
     Mult Scler. 2007;13:856-864.
     PubMed     Related articles    Abstract available
     
     
     
106. LEHMENSIEK V , Sussmuth S, Tauscher G, Brettschneider J, et al
     Cerebrospinal fluid proteome profile in multiple sclerosis.
     Mult Scler. 2007;13:840-9.
     PubMed     Related articles    Abstract available
     
     
     
107. LUCAS R , Ponsonby AL, McMichael A, van der Mei I, et al
     Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function.
     Mult Scler. 2007;13:827-39.
     PubMed     Related articles    Abstract available
     
     
     
108. BROADLEY S
     Could vitamin D be the answer to multiple sclerosis?
     Mult Scler. 2007;13:825-6.
     PubMed     Related articles   
     
     
     
109. TRIP SA , Schlottmann PG, Jones SJ, Li WY, et al
     Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis.
     Mult Scler. 2007;13:875-9.
     PubMed     Related articles    Abstract available
     
     
     July 2007
110. MARROSU F , Maleci A, Cocco E, Puligheddu M, et al
     Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. HOLLEY JE , Newcombe J, Winyard PG, Gutowski NJ, et al
     Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. KOS D , D'Hooghe MB, Nagels G, Duportail M, et al
     Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. JEFFERY DR
     Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. POHLAU D , Przuntek H, Sailer M, Bethke F, et al
     Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. GLANZ BI , Holland CM, Gauthier SA, Amunwa EL, et al
     Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. DEBOUVERIE M , Pittion-Vouyovitch S, Louis S, Roederer T, et al
     Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. ANN MARRIE R , Goldman M
     Validity of performance scales for disability assessment in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. CETIN K , Johnson KL, Ehde DM, Kuehn CM, et al
     Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. TRIPOLITI E , Campbell C, Pring TR, Taylor-Goh S, et al
     Quality of life in multiple sclerosis: should clinicians trust proxy ratings?
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. YOUNES M , Hill J, Quinless J, Kilduff M, et al
     Internet-based cognitive testing in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. SWEETLAND J , Riazi A, Cano SJ, Playford ED, et al
     Vocational rehabilitation services for people with multiple sclerosis: what patients want from clinicians and employers.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. DE LAS HERAS V , de Andres C, Tellez N, Tintore M, et al
     Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. MONTERO JL , Cerezo A, Fraga E, Barrera P, et al
     Acute liver failure in a patient with multiple sclerosis treated with interferon-{beta}.
     Mult Scler. 2007;13:820.
     PubMed     Related articles   
     
     
     
124. PENDER MP , Ferguson SM
     Dysarthria and dysphagia due to the opercular syndrome in multiple sclerosis.
     Mult Scler. 2007;13:817-9.
     PubMed     Related articles    Abstract available
     
     
     
125. PICHIECCHIO A , Bergamaschi R, Tavazzi E, Romani A, et al
     Bilateral trigeminal enhancement on magnetic resonance imaging in a patient with multiple sclerosis and trigeminal neuralgia.
     Mult Scler. 2007;13:814-6.
     PubMed     Related articles    Abstract available
     
     
     
126. KEZELE IB , Chen JT, Arnold DL, Collins DL, et al
     The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis.
     Mult Scler. 2007;13:809-13.
     PubMed     Related articles    Abstract available
     
     
     
127. GOMEZ-CHOCO MJ , Iranzo A, Blanco Y, Graus F, et al
     Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis.
     Mult Scler. 2007;13:805-8.
     PubMed     Related articles    Abstract available
     
     
     
128. CASADO V , Romero L, Gubieras L, Alonso L, et al
     An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.
     Mult Scler. 2007;13:800-4.
     PubMed     Related articles    Abstract available
     
     
     
129. LODE K , Larsen JP, Bru E, Klevan G, et al
     Patient information and coping styles in multiple sclerosis.
     Mult Scler. 2007;13:792-9.
     PubMed     Related articles    Abstract available
     
     
     
130. PATTI F , Pozzilli C, Montanari E, Pappalardo A, et al
     Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.
     Mult Scler. 2007;13:783-91.
     PubMed     Related articles    Abstract available
     
     
     
131. BJARNADOTTIR OH , Konradsdottir AD, Reynisdottir K, Olafsson E, et al
     Multiple sclerosis and brief moderate exercise. A randomised study.
     Mult Scler. 2007;13:776-82.
     PubMed     Related articles    Abstract available
     
     
     
132. SOLARI A , Acquarone N, Pucci E, Martinelli V, et al
     Communicating the diagnosis of multiple sclerosis - a qualitative study.
     Mult Scler. 2007;13:763-9.
     PubMed     Related articles    Abstract available
     
     
     
133. VALENZUELA RM , Costello K, Chen M, Said A, et al
     Clinical response to glatiramer acetate correlates with modulation of IFN-{gamma} and IL-4 expression in multiple sclerosis.
     Mult Scler. 2007;13:754-62.
     PubMed     Related articles    Abstract available
     
     
     
134. BROUSSEAU K , Arciniegas D, Carmosino M, Corboy J, et al
     The differential diagnosis of Axis I psychopathology presenting to a university-based multiple sclerosis clinic.
     Mult Scler. 2007;13:749-753.
     PubMed     Related articles    Abstract available
     
     
     
135. SECIL Y , Yetimalar Y, Gedizlioglu M, Arpaci E, et al
     Sexual dysfunction and sympathetic skin response recorded from the genital region in women with multiple sclerosis.
     Mult Scler. 2007;13:742-8.
     PubMed     Related articles    Abstract available
     
     
     
136. UZUNER N , Ozkan S, Cinar N
     Cerebrovascular reactivity in multiple sclerosis patients.
     Mult Scler. 2007;13:737-41.
     PubMed     Related articles    Abstract available
     
     
     
137. BENEDICT RH , Bruce J, Dwyer MG, Weinstock-Guttman B, et al
     Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
     Mult Scler. 2007;13:722-30.
     PubMed     Related articles    Abstract available
     
     
     
138. VRENKEN H , Pouwels PJ, Ropele S, Knol DL, et al
     Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
     Mult Scler. 2007;13:708-16.
     PubMed     Related articles    Abstract available
     
     
     
139. UKKONEN M , Wu K, Reipert B, Dastidar P, et al
     Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis.
     Mult Scler. 2007;13:701-707.
     PubMed     Related articles    Abstract available
     
     
     
140. LUNDMARK F , Salter H, Hillert J
     An association study of two functional promotor polymorphisms in the myeloperoxidase (MPO) gene in multiple sclerosis.
     Mult Scler. 2007;13:697-700.
     PubMed     Related articles    Abstract available
     
     
     
141. PELAYO R , Tintore M, Rovira A, Rio J, et al
     Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort.
     Mult Scler. 2007;13:731-6.
     PubMed     Related articles    Abstract available
     
     
     
142. NIELSEN JM , Moraal B, Polman CH, Poppe P, et al
     Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results.
     Mult Scler. 2007;13:717-21.
     PubMed     Related articles    Abstract available
     
     
     
143. MARRIE RA , Cutter G, Tyry T, Campagnolo D, et al
     Validation of the NARCOMS registry: diagnosis.
     Mult Scler. 2007;13:770-5.
     PubMed     Related articles    Abstract available
     
     
     June 2007
144. MANNELLO F , Tonti GA, Canestrari F
     The ;never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a l
     Mult Scler. 2007;13:687-90.
     PubMed     Related articles   
     
     
     
145. ALANOGLU G , Kilbas S, Arslan C, Senol A, et al
     Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis.
     Mult Scler. 2007;13:683-5.
     PubMed     Related articles    Abstract available
     
     
     
146. PORTACCIO E , Amato MP, Siracusa G, Pagliai F, et al
     Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases.
     Mult Scler. 2007;13:676-8.
     PubMed     Related articles    Abstract available
     
     
     
147. MAGHZI AH , Etemadifar M, Shaygannejad V, Saadatnia M, et al
     Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
     Mult Scler. 2007;13:673-5.
     PubMed     Related articles    Abstract available
     
     
     
148. BARNES MS , Bonham MP, Robson PJ, Strain JJ, et al
     Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers.
     Mult Scler. 2007;13:670-2.
     PubMed     Related articles    Abstract available
     
     
     
149. WASAY M , Ali S, Khatri IA, Hassan A, et al
     Multiple sclerosis in Pakistan.
     Mult Scler. 2007;13:668-9.
     PubMed     Related articles    Abstract available
     
     
     
150. EDMONDS P , Vivat B, Burman R, Silber E, et al
     ;Fighting for everything': service experiences of people severely affected by multiple sclerosis.
     Mult Scler. 2007;13:660-7.
     PubMed     Related articles    Abstract available
     
     
     
151. MCAULEY E , Motl RW, Morris KS, Hu L, et al
     Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial.
     Mult Scler. 2007;13:652-9.
     PubMed     Related articles    Abstract available
     
     
     
152. BENITO-LEON J , Martinez-Martin P, Frades B, Martinez-Gines ML, et al
     Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
     Mult Scler. 2007;13:645-51.
     PubMed     Related articles    Abstract available
     
     
     
153. GOVEROVER Y , Genova H, Hillary F, Deluca J, et al
     The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis.
     Mult Scler. 2007;13:636-44.
     PubMed     Related articles    Abstract available
     
     
     
154. SOLLOM AC , Kneebone II
     Treatment of depression in people who have multiple sclerosis.
     Mult Scler. 2007;13:632-5.
     PubMed     Related articles    Abstract available
     
     
     
155. DEBOUVERIE M , Taillandier L, Pittion-Vouyovitch S, Louis S, et al
     Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.
     Mult Scler. 2007;13:626-31.
     PubMed     Related articles    Abstract available
     
     
     
156. DE SEZE J , Debouverie M, Waucquier N, Steinmetz G, et al
     Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
     Mult Scler. 2007;13:622-5.
     PubMed     Related articles    Abstract available
     
     
     
157. SORENSEN P , Koch-Henriksen N, Bendtzen K
     Are ex vivo neutralising antibodies against IFN-{beta} always detrimental to therapeutic efficacy in multiple sclerosis?
     Mult Scler. 2007;13:616-21.
     PubMed     Related articles    Abstract available
     
     
     
158. HAWKES CH
     Smoking is a risk factor for multiple sclerosis: a metanalysis.
     Mult Scler. 2007;13:610-5.
     PubMed     Related articles    Abstract available
     
     
     
159. ALVAREZ-LAFUENTE R , Garcia-Montojo M, De Las Heras V, Bartolome M, et al
     JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.
     Mult Scler. 2007;13:590-5.
     PubMed     Related articles    Abstract available
     
     
     
160. DATTA P , Harbo HF, Ryder LP, Akesson E, et al
     A follow-up study of Nordic multiple sclerosis candidate gene regions.
     Mult Scler. 2007;13:584-9.
     PubMed     Related articles    Abstract available
     
     
     
161. ALVAREZ-LAFUENTE R , de Las Heras V, Garcia-Montojo M, Bartolome M, et al
     Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.
     Mult Scler. 2007;13:578-83.
     PubMed     Related articles    Abstract available
     
     
     
162. FARRELL RA , Giovannoni G
     Measuring and management of Anti-Interferon Beta Antibodies in subjects with Multiple Sclerosis.
     Mult Scler. 2007;13:567-77.
     PubMed     Related articles    Abstract available
     
     
     
163. FAINARDI E , Castellazzi M, Bellini T, Dallocchio F, et al
     Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
     Mult Scler. 2007;13:691-2.
     PubMed     Related articles   
     
     
     
164. JACOB A , Pittock SJ
     Gastroparesis in multiple sclerosis.
     Mult Scler. 2007;13:686.
     PubMed     Related articles   
     
     
     
165. HENGSTMAN GJ , Wesseling P, Frenken CW, Jongen PJ, et al
     Neuromyelitis optica with clinical and histopathological involvement of the brain.
     Mult Scler. 2007;13:679-82.
     PubMed     Related articles    Abstract available
     
     
     May 2007
166. SOLARO C , Brichetto G, Casadio M, Roccatagliata L, et al
     Subtle upper limb impairment in asymptomatic multiple sclerosis subjects.
     Mult Scler. 2007;13:428-32.
     PubMed     Related articles    Abstract available
     
     
     
167. LUCAS M , Suarez R, Marcos A, Solano F, et al
     Arg113His mutation of vanishing white matter is not present in multiple sclerosis.
     Mult Scler. 2007;13:424-7.
     PubMed     Related articles    Abstract available
     
     
     
168. NIELSEN TR , Pedersen M, Rostgaard K, Frisch M, et al
     Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals.
     Mult Scler. 2007;13:420-3.
     PubMed     Related articles    Abstract available
     
     
     
169. PATTI F , Amato MP, Battaglia MA, Pitaro M, et al
     Caregiver quality of life in multiple sclerosis: a multicentre Italian study.
     Mult Scler. 2007;13:412-9.
     PubMed     Related articles    Abstract available
     
     
     
170. SCHERER P , Penner IK, Rohr A, Boldt H, et al
     The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.
     Mult Scler. 2007;13:402-11.
     PubMed     Related articles    Abstract available
     
     
     
171. MONTEL SR , Bungener C
     Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
     Mult Scler. 2007;13:393-401.
     PubMed     Related articles    Abstract available
     
     
     
172. BEISKE AG , Naess H, Aarseth JH, Andersen O, et al
     Health-related quality of life in secondary progressive multiple sclerosis.
     Mult Scler. 2007;13:386-92.
     PubMed     Related articles    Abstract available
     
     
     
173. LOVERA J , Bagert B, Smoot K, Morris CD, et al
     Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.
     Mult Scler. 2007;13:376-85.
     PubMed     Related articles    Abstract available
     
     
     
174. WOOLMORE JA , Stone M, Pye EM, Partridge JM, et al
     Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.
     Mult Scler. 2007;13:369-75.
     PubMed     Related articles    Abstract available
     
     
     
175. GOODMAN AD , Cohen JA, Cross A, Vollmer T, et al
     Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.
     Mult Scler. 2007;13:357-68.
     PubMed     Related articles    Abstract available
     
     
     
176. FEUILLET L , Pelletier J, Suchet L, Rico A, et al
     Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a: a pilot study.
     Mult Scler. 2007;13:348-56.
     PubMed     Related articles    Abstract available
     
     
     
177. DI REZZE S , Gupta S, Durastanti V, Millefiorini E, et al
     An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis.
     Mult Scler. 2007;13:343-7.
     PubMed     Related articles    Abstract available
     
     
     
178. O'ROURKE K , Walsh C, Antonelli G, Hutchinson M, et al
     Predicting beta-interferon failure in relapsing-remitting multiple sclerosis.
     Mult Scler. 2007;13:336-42.
     PubMed     Related articles    Abstract available
     
     
     
179. SARCHIELLI P , Zaffaroni M, Floridi A, Greco L, et al
     Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-{beta} 1a, and high doses of immunoglobulins.
     Mult Scler. 2007;13:313-31.
     PubMed     Related articles    Abstract available
     
     
     
180. DERUAZ CA , Spertini F, Souza Lima F, Du Pasquier RA, et al
     Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids.
     Mult Scler. 2007;13:559-60.
     PubMed     Related articles   
     
     
     
181. MINDEN SL , Frankel D, Hadden L, Hoaglin DC, et al
     Access to health care for people with multiple sclerosis.
     Mult Scler. 2007;13:547-58.
     PubMed     Related articles    Abstract available
     
     
     
182. IEZZONI L , Ngo L
     Health, disability, and life insurance experiences of working-age persons with multiple sclerosis.
     Mult Scler. 2007;13:534-46.
     PubMed     Related articles    Abstract available
     
     
     
183. MILLER L , Mattison P, Paul L, Wood L, et al
     The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis.
     Mult Scler. 2007;13:527-33.
     PubMed     Related articles    Abstract available
     
     
     
184. ZABAD RK , Metz LM, Todoruk TR, Zhang Y, et al
     The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.
     Mult Scler. 2007;13:517-26.
     PubMed     Related articles    Abstract available
     
     
     
185. SCHACH S , Scholz M, Wolinsky JS, Kappos L, et al
     Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation.
     Mult Scler. 2007;13:509-16.
     PubMed     Related articles    Abstract available
     
     
     
186. ZIVADINOV R , Locatelli L, Cookfair D, Srinivasaraghavan B, et al
     I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
     Mult Scler. 2007;13:490-501.
     PubMed     Related articles    Abstract available
     
     
     
187. AUDOIN B , Davies G, Rashid W, Fisniku L, et al
     Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis.
     Mult Scler. 2007;13:483-489.
     PubMed     Related articles    Abstract available
     
     
     
188. LINDQUIST S , Bodammer N, Kaufmann J, Konig F, et al
     Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant.
     Mult Scler. 2007;13:471-82.
     PubMed     Related articles    Abstract available
     
     
     
189. HAMAMCIOGLU K , Reder A
     Interferon-{beta} regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
     Mult Scler. 2007;13:459-70.
     PubMed     Related articles    Abstract available
     
     
     
190. OTAEGUI D , Saenz A, Ruiz-Martinez J, Olaskoaga J, et al
     UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor.
     Mult Scler. 2007;13:454-8.
     PubMed     Related articles    Abstract available
     
     
     
191. SIDOTI A , Antognelli C, Rinaldi C, D'Angelo R, et al
     Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
     Mult Scler. 2007;13:446-53.
     PubMed     Related articles    Abstract available
     
     
     
192. CALLANDER M , Haghighi S, Landtblom AM, Ahlgren CE, et al
     Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
     Mult Scler. 2007;13:441-5.
     PubMed     Related articles    Abstract available
     
     
     
193. ROVARIS M , Comi G, Rocca MA, Valsasina P, et al
     Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial.
     Mult Scler. 2007;13:502-8.
     PubMed     Related articles    Abstract available
     
     
     
194. FAINARDI E , Castellazzi M, Bellini T, Dallocchio F, et al
     Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
     Mult Scler. 2007;13:561-2.
     PubMed     Related articles   
     
     
     April 2007
195. GARG N , Weinstock-Guttman B, Bhasi K, Locke J, et al
     An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. TROJAN DA , Arnold DL, Collet JP, Shapiro S, et al
     Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. FOX RJ , Lee JC, Rudick RA
     Optimal reference population for the multiple sclerosis functional composite.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. ZHANG Y , Zabad R, Wei X, Metz LM, et al
     Deep grey matter 'black T2' on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. SOON D , Tozer DJ, Altmann DR, Tofts PS, et al
     Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. SAITO H , Suzuki M, Asakawa T, Kato S, et al
     Retinopathy in a multiple sclerosis patient undergoing interferon-therapy.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. TANAKA K , Tani T, Tanaka M, Saida T, et al
     Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. COCCO E , Marchi P, Sardu C, Russo P, et al
     Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. BAMER AM , Cetin K, Amtmann D, Bowen JD, et al
     Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study.
     Mult Scler. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
204. CABRERA-GOMEZ JA , Galarraga-Inza J, Coro-Antich RM, Real-Gonzalez Y, et al
     Down's syndrome and neuromyelitis optica (Devic's disease). An autopsy-proven case.
     Mult Scler. 2007;13:433-6.
     PubMed     Related articles    Abstract available
     
     
     
205. NAKAMURA M , Nakashima I, Sato S, Miyazawa I, et al
     Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.
     Mult Scler. 2007;13:332-5.
     PubMed     Related articles    Abstract available
     
     
     March 2007
206. AYATOLLAHI P , Nafissi S, Eshraghian MR, Kaviani H, et al
     Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
     Mult Scler. 2007;13:275-7.
     PubMed     Related articles    Abstract available
     
     
     
207. CLAESSON IM , Ytterberg C, Johansson S, Almkvist O, et al
     Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
     Mult Scler. 2007;13:272-4.
     PubMed     Related articles    Abstract available
     
     
     
208. CENTONZE D , Petta F, Versace V, Rossi S, et al
     Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis.
     Mult Scler. 2007;13:269-71.
     PubMed     Related articles    Abstract available
     
     
     
209. ARES B , Prieto JM, Lema M, Dapena D, et al
     Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain).
     Mult Scler. 2007;13:262-264.
     PubMed     Related articles    Abstract available
     
     
     
210. FRICSKA-NAGY Z , Bencsik K, Rajda C, Fuvesi J, et al
     Epidemiology of familial multiple sclerosis in Hungary.
     Mult Scler. 2007;13:260-1.
     PubMed     Related articles    Abstract available
     
     
     
211. AMIRZARGAR A , Khosravi F, Dianat S, Hushmand F, et al
     Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients.
     Mult Scler. 2007;13:253-5.
     PubMed     Related articles    Abstract available
     
     
     
212. MAS A , Martinez A, de Las Heras V, Bartolome M, et al
     The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population.
     Mult Scler. 2007;13:250-2.
     PubMed     Related articles    Abstract available
     
     
     
213. SHERMAN TE , Rapport LJ, Hanks RA, Ryan KA, et al
     Predictors of well-being among significant others of persons with multiple sclerosis.
     Mult Scler. 2007;13:238-49.
     PubMed     Related articles    Abstract available
     
     
     
214. MEYER-HEIM A , Rothmaier M, Weder M, Kool J, et al
     Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis.
     Mult Scler. 2007;13:232-7.
     PubMed     Related articles    Abstract available
     
     
     
215. CREANGE A , Serre I, Levasseur M, Audry D, et al
     Walking capacities in multiple sclerosis measured by global positioning system odometer.
     Mult Scler. 2007;13:220-3.
     PubMed     Related articles    Abstract available
     
     
     
216. MOHR DC , Hart SL, Julian L, Tasch ES, et al
     Screening for depression among patients with multiple sclerosis: two questions may be enough.
     Mult Scler. 2007;13:215-9.
     PubMed     Related articles    Abstract available
     
     
     
217. SOMINANDA A , Rot U, Suoniemi M, Deisenhammer F, et al
     Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity.
     Mult Scler. 2007;13:208-14.
     PubMed     Rela